» Articles » PMID: 20809287

Can Diffusion Tensor Metrics Help in Preoperative Grading of Diffusely Infiltrating Astrocytomas? A Retrospective Study of 36 Cases

Overview
Journal Neuroradiology
Specialties Neurology
Radiology
Date 2010 Sep 3
PMID 20809287
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Diffusion weighted imaging and diffusion tensor imaging (DTI) give information about the amount and directionality of water diffusion occurring in a given tissue. Here we study the role of diffusion tensor metrics including fractional anisotropy (FA) and spherical anisotropy (CS) in preoperative grading of diffusely infiltrating astrocytomas.

Methods: We performed DTI in 38 patients with pathologically proven diffusely infiltrating astrocytomas, who were classified into two groups, i.e., 15 patients with high-grade astrocytoma (HGAs, WHO grade III and IV) and 23 patients with low-grade astrocytoma (LGAs, WHO grade II). We measured maximum FA and minimum CS values in all cases from tumor. Histopathological diagnosis was established in all cases.

Results: The mean maximum FA values were higher in HGA (0.583 ± 0.104) than LGA (0.295 ± 0.058), while mean minimum CS values were lower in HGA (0.42 ± 0.121) than LGA (0.722 ± 0.061). The difference in the diffusion tensor indices between HGA and LGA was found to be statistically significant with P value of <0.001. Keeping cutoff FA value of 0.4, all HGAs showed higher maximum FA values, and all LGAs showed lower maximum FA values. Also, all HGAs showed minimum CS values less than a cutoff value of 0.6, and all LGAs showed minimum CS values higher than 0.6.

Conclusion: Diffusion tensor metrics such as maximum FA and minimum CS can help to differentiate HGA from LGA.

Citing Articles

Multiband diffusion tensor imaging for presurgical mapping of motor and language pathways in patients with brain tumors.

Jenabi M, Young R, Moreno R, Gene M, Cho N, Otazo R J Neuroimaging. 2021; 31(4):784-795.

PMID: 33817896 PMC: 8286293. DOI: 10.1111/jon.12859.


Assessing neuraxial microstructural changes in a transgenic mouse model of early stage Amyotrophic Lateral Sclerosis by ultra-high field MRI and diffusion tensor metrics.

Gatto R, Weissmann C, Amin M, Finkielsztein A, Sumagin R, Mareci T Animal Model Exp Med. 2020; 3(2):117-129.

PMID: 32613171 PMC: 7323706. DOI: 10.1002/ame2.12112.


Brain Tumor Characterization Using Multibiometric Evaluation of MRI.

Durmo F, Latt J, Rydelius A, Engelholm S, Kinhult S, Askaner K Tomography. 2018; 4(1):14-25.

PMID: 29675474 PMC: 5903291. DOI: 10.18383/j.tom.2017.00020.


Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.

Raja R, Sinha N, Saini J, Mahadevan A, Rao K, Swaminathan A Neuroradiology. 2016; 58(12):1217-1231.

PMID: 27796448 DOI: 10.1007/s00234-016-1758-y.


Diffusion tensor imaging in evaluation of posterior fossa tumors in children on a 3T MRI scanner.

Assis Z, Saini J, Ranjan M, Gupta A, Sabharwal P, Naidu P Indian J Radiol Imaging. 2016; 25(4):445-52.

PMID: 26752824 PMC: 4693394. DOI: 10.4103/0971-3026.169444.


References
1.
Law M, Yang S, Babb J, Knopp E, Golfinos J, Zagzag D . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol. 2004; 25(5):746-55. PMC: 7974484. View

2.
Le Bihan D, Mangin J, Poupon C, Clark C, Pappata S, Molko N . Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging. 2001; 13(4):534-46. DOI: 10.1002/jmri.1076. View

3.
Watanabe M, Tanaka R, Takeda N . Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology. 1992; 34(6):463-9. DOI: 10.1007/BF00598951. View

4.
Shimizu H, Kumabe T, Shirane R, Yoshimoto T . Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol. 2000; 21(4):659-65. PMC: 7976633. View

5.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View